Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study
- 25 January 2025
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 46 (5) , 2209-2216
Abstract
Objective Plasma glial fibrillary acidic protein (pGFAP) and plasma neurofilament light chain (pNfL) levels reflect astrocyte activation and neuronal damage, respectively. Whether these phenomena play a role in migraine is unknown. This study aimed to compare pGFAP and pNfL levels in patients with chronic migraine (CM) and age-matched controls and to analyze their relation with clinical features. Methods The study evaluated two independent cohorts of patients, including in total 58 CM and 69 controls. pGFAP and pNfL were quantified with single molecule array (Simoa) technology. Demographic and clinical data were collected for each subject; differences in NfL/GFAP levels between CM and controls were evaluated in analyses adjusted for the effect of age and sex; clinical characteristics associated with NfL/GFAP levels were separately evaluated in the two cohorts. Results In both cohorts, we did not find a significant difference in pGFAP or pNFL levels between CM and matched controls. The study did not find any correlation between pGFAP or pNfL levels and any migraine characteristics (namely presence of migraine aura, attack frequency, migraine intensity, years of disease). Conclusions Our negative results support the assumption that migraine represents a benign condition, characterized by transient functional brain alterations and not by the accumulation over time of neuroaxonal damage and/or associated astrocyte activation detectable by neurodegeneration marker proteins.Keywords
Funding Information
- Ministero della Salute (ricerca corrente to IRCCS Istituto Auxologico Italiano DACEFA 2022_03_03)
This publication has 35 references indexed in Scilit:
- Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosisAnnals of Clinical and Translational Neurology, 2022
- Blood GFAP as an emerging biomarker in brain and spinal cord disordersNature Reviews Neurology, 2022
- White Matter Lesions in MigraineThe American Journal of Pathology, 2021
- A multicentre validation study of the diagnostic value of plasma neurofilament lightNature Communications, 2021
- S100B and neuron‐specific enolase levels in episodic and chronic migraineActa Neurologica Scandinavica, 2020
- Neurochemical regulation of the expression and function of glial fibrillary acidic protein in astrocytesGlia, 2019
- The metabolic face of migraine — from pathophysiology to treatmentNature Reviews Neurology, 2019
- Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related DisordersMolecular Neurobiology, 2019
- Neurofilaments as biomarkers in neurological disordersNature Reviews Neurology, 2018
- Grey matter alterations in migraine: A systematic review and meta-analysisNeuroImage: Clinical, 2017